Skip to Content

Lymphocyte Transformation Test (LTT) for MAP Diagnosis 

Cellular Immune Profiling for Early Detection of Paratuberculosis

Introduction to the Lymphocyte Transformation Test

The Lymphocyte Transformation Test (LTT) is a cell-mediated immune assay designed to measure the proliferative response of lymphocytes, specifically peripheral blood mononuclear cells (PBMCs), upon exposure to specific antigens. In the context of paratuberculosis (Johne’s disease), caused by Mycobacterium avium subspecies paratuberculosis (MAP), LTT serves as an in vitro indicator of host immune reactivity to MAP antigens.

This assay plays a vital role in monitoring the cellular immune response in vaccinated or naturally infected animals and has proven to be particularly valuable during the early stages of infection, when humoral immune responses are not yet detectable through serological methods like ELISA.

Principle of the Technique

LTT is based on the principle that sensitized T lymphocytes, when exposed again to a specific antigen (in this case, MAP antigen), undergo blast transformation and begin to proliferate. The test involves isolating PBMCs from blood samples, culturing them in vitro, and then stimulating them with MAP-specific protoplasmic antigens.

The proliferation of lymphocytes is typically quantified using one of the following methods:

  • Incorporation of radioactive thymidine (^3H-thymidine) into newly synthesized DNA
  • Use of colorimetric assays (e.g., MTT, Alamar Blue)
  • Flow cytometry to measure activation markers or cell counts

The response is measured by calculating the Stimulation Index (SI), which is the ratio of the response in antigen-stimulated cultures to the response in unstimulated control cultures.

Immunological Performance

LTT offers insights into the cellular immune competence of the host against MAP infection:

  • In vaccinated animals, particularly goats, the Stimulation Index becomes significantly elevated from 30 days post-vaccination onward, indicating T-cell activation in response to the vaccine antigen (Singh et al. 2010).
  • In heavily infected animals, the transformation response may become suppressed or erratic, possibly due to immune exhaustion or antigen overload.
  • In noninfected populations, background positivity may still occur, especially in herds with known historical exposure to MAP, reflecting environmental sensitization (Stabel & Goff 2004).

These variations highlight the need for careful interpretation of LTT results within the epidemiological and clinical context.

Advantages of LTT in MAP Diagnosis

1. Detection in Early Infection

LTT can detect MAP-specific immune responses before seroconversion, making it valuable for early diagnosis when other methods (e.g., ELISA) might be negative.

2. Monitoring Vaccine Response

The test is highly suitable for evaluating the efficacy of vaccines, offering quantitative data on T-cell activation post-vaccination.

3. Non-Invasive Sampling

Only blood samples are required, which are easier and safer to collect than tissues or fecal material.

4. Insight into Host Immunity

LTT provides a functional assessment of the host immune system’s ability to recognize and respond to MAP—essential for understanding disease dynamics and resistance.

Applications in Research and Field Diagnostics

LTT has been applied in multiple research and field settings to:

  • Characterize immune kinetics post-vaccination
  • Study the immunopathogenesis of MAP infection in ruminants
  • Compare immune responses in resistant vs. susceptible breeds or populations
  • Complement other diagnostic methods such as ELISA and PCR in multi-tier diagnostic strategies

When integrated with other cellular and molecular assays, LTT contributes to a comprehensive understanding of host–pathogen interactions in paratuberculosis.

Conclusion

The Lymphocyte Transformation Test is a sensitive and informative assay for evaluating cell-mediated immunity in MAP-infected or vaccinated animals. Though technically demanding, it fills a critical gap in the diagnostic toolbox by enabling early detection, assessment of vaccine-induced protection, and understanding of immune variability across herds.

As diagnostic technologies evolve, combining LTT with modern techniques like cytokine profiling, transcriptomics, or high-throughput flow cytometry may unlock even deeper insights into the complex immune responses associated with MAP infection and contribute to improved control strategies for Johne’s disease in livestock.